Frank Morich - 02 Mar 2026 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Role
Director
Signature
/s/ Frank Morich by Chris Nenno, as Attorney-in-Fact
Issuer symbol
CATX
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
04 Mar 2026, 16:38:07 UTC
Previous filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morich Frank Director C/O PERSPECTIVE THERAPEUTICS, INC., 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE /s/ Frank Morich by Chris Nenno, as Attorney-in-Fact 04 Mar 2026 0001748615

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CATX Stock option (right to buy) Award +50,000 $0.000000* 50,000 02 Mar 2026 Common Stock 50,000 $5.35 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option grant was approved by the Issuer's Board of Directors on January 26, 2026, with a grant date of March 2, 2026, and represents the Reporting Person's annual equity award for 2026.
F2 Option vests in full on March 2, 2027, subject to the Reporting Person's continued service on the vesting date.